Envestnet Asset Management Inc. lessened its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 21.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,655 shares of the company's stock after selling 11,745 shares during the period. Envestnet Asset Management Inc.'s holdings in Revvity were worth $4,513,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in RVTY. T. Rowe Price Investment Management Inc. grew its holdings in shares of Revvity by 16.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock valued at $2,317,170,000 after acquiring an additional 2,969,326 shares in the last quarter. Vanguard Group Inc. grew its holdings in Revvity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company's stock worth $1,594,930,000 after purchasing an additional 156,679 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Revvity by 17.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after purchasing an additional 1,151,821 shares during the period. Janus Henderson Group PLC grew its holdings in Revvity by 0.4% during the fourth quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock worth $709,725,000 after purchasing an additional 23,650 shares during the period. Finally, EdgePoint Investment Group Inc. grew its holdings in Revvity by 51.1% during the fourth quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock worth $452,939,000 after purchasing an additional 1,372,456 shares during the period. Institutional investors own 86.65% of the company's stock.
Revvity Trading Up 1.1%
NYSE RVTY traded up $1.05 on Tuesday, reaching $96.09. The company had a trading volume of 255,690 shares, compared to its average volume of 1,166,948. The firm has a market cap of $11.33 billion, a price-to-earnings ratio of 40.69, a P/E/G ratio of 2.61 and a beta of 0.98. Revvity Inc. has a fifty-two week low of $87.70 and a fifty-two week high of $129.50. The business has a 50 day moving average of $95.55 and a two-hundred day moving average of $103.13. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.58 and a quick ratio of 2.99.
Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, topping analysts' consensus estimates of $1.14 by $0.04. Revvity had a return on equity of 7.73% and a net margin of 10.35%. The firm had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. During the same period last year, the business posted $1.22 EPS. The business's revenue was up 4.1% compared to the same quarter last year. Analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.
Revvity Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.29%. Revvity's payout ratio is currently 11.91%.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on RVTY shares. Barclays reduced their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. The Goldman Sachs Group reduced their price objective on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Bank of America reduced their price objective on Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Stifel Nicolaus cut their price target on Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research note on Tuesday. Finally, UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and cut their price target for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. Five equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $121.94.
Read Our Latest Report on Revvity
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
See Also

Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.